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Summary 
 3, 4, Methylenedioxymetamphetamine (M.D.M.A., Ecstasy) is a modified 
amphetamine with stimulant and hallucinogenic properties. Ecstasy has been 
increasingly abused in Dublin in recent years. It is commonly perceived by users as 
a safe drug. We report a case of prolonged psychosis following brief recreational use 
of Ecstasy. 
Introduction 
3, 4, Methylenedioxymetamphetamine (M.D.M.A., Ecstasy, X.T.C.) is a modified 
amphetamine reported to have both stimulant and hallucinogenic properties1. It is an illegal 
synthetically produced “designer drug” used as a recreational drug of abuse. 
 Anecdotal reports suggest that M.D.M.A. is becoming increasingly abused in certain areas of 
Dublin. Sources from the Garda Drug Squad (Personal Communications) confirm a steady increase in 
seizures of Ecstasy since early 1991. Prior to that date there were no reported seizures. The “street” 
price is currently between £20 - £30 per tablet. 
Little is known of the drug’s mechanism of action or possible neurotoxic and 
neurodegenerative effects in humans. In vivo brain studies in primates2 suggest that M.D.M.A. acts 
primarily via the serotonergic system. It would appear to produce an acute depletion of 5-
Hydroxytryptamine (5HT) followed by a more long lasting degeneration of nerve terminals. 
Interestingly this effect is reported to be blocked by the 5HT uptake inhibitor Fluoxetine suggesting an 
active uptake to M.D.M.A. by serotonergic neurons3. 
In humans, recreational use of Ecstasy is reported to induce a state of well being, a heightened 
state of consciousness, an intense sense of “closeness” to others and increased sexual arousal4,5,6. 
M.D.A. (Methylenedioxyamphetamine), an analog of M.D.M.A., indeed is known colloquially as the 
“love drug”. Visual hallucinations were reported in one study in 20% of recreational users. Other 
reported effects include tachycardia, increased B.P., dilated pupils, dry mouth, bruxism and trismus . 
A “hang-over” effect commonly occurs the following day characterized by muscular pain, fatigue, 
depression, poor concentration and irritability. 
There have been recent reports in the literature of chronic psychosis occurring after sustained 
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An eighteen year unemployed male was transferred to our care from the forensic service. He 
had been arrested one week earlier following a minor infringement but was noted to be in a very 
disturbed and aggressive state at the time. 
He had reportedly taken M.D.M.A. (1/2 tablet) on only four separate occasions at weekends, 
the last time being forty eight hours prior to his arrest. He had been smoking cannabis for 
approximately five months but had not experienced any adverse reactions. He denied any other 
substance abuse during this time. There is no past history of disturbed behaviour, nor any psychiatric 
or forensic history. He had sustained an undisplaced frontal skull fracture two months earlier. There 
was no loss of consciousness or amnesia, neurological observation was normal and the patient was 
discharged from hospital within twenty four hours. No abnormal sequelae were noted following 
discharge. His mother has a history of psychotic depression with paranoid delusions. 
On admission the patient was perplexed and easily distractable. His behaviour was bizarre 
with prominent mannerisms such as boxing thin air and repeatedly beating his chest. Mood was labile 
with frequent aggressive outbursts. He admitted to hearing voices and appeared to be actively 
hallucinating on a number of occasions. He exhibited paranoid delusions regarding para military 
organisations in whose headquarters he presently believed he was. He was disorientated in both time 
and place. 
Physical examination was normal except for some superficial bruising to the limbs. Routine 
haematologic investigations including serology for hepatitis were normal. A neurological review and 
C.T. scan revealed no abnormality. Urinalysis was positive for Cannabis and Benzodiazepines only. 
The specimen was taken more than one week after ingestion of M.D.M.A. and therefore it was likely 
that any amphetamine like compound would have been already eliminated. It was also taken after 
Diazepam had been administered to the patient, thus explaining the presence of Benzodiazepines. 
The patient was initially commenced on increasing doses of Haloperidol (40mg daily) and 
Diazepam 30mg daily but with little improvement in his mental state over the next two weeks. 
Carbamazepine (200mg t.d.s.) was added as a possible adjunct to neuroleptics but again without 
significant effect. The patient was then commenced on Clopenthixol acetate 50-100mg, i.m., every 24-
72 hours over the next two weeks (total dosage 600mg). His condition gradually improved with 
eventual resolution of his psychosis and disorientation. 
He was discharged from hospital two months after his initial presentation. Regular follow-up 
at the out patient department has to date revealed no abnormality in mental state. 
Discussion 
Our patient developed a prolonged psychotic reaction following ingestion of the drug 
M.D.M.A. McGuire and Fahy7 recently reported on two cases of chronic paranoid psychosis following 
misuse of M.D.M.A. In both these cases however the drug had been abused for much longer periods 
(18 months and 2 years respectively) and in much larger quantities. In contrast our patient had used 
only a half tablet on four separate occasions over a 1 month period. Other reported adverse 
psychological sequeli include recurrent psychosis and L.S.D. like flashbacks8. 
 
As with other reported cases a number of other factors may have contributed to our patient’s 
reaction. He had a family history of a paranoid psychosis. In addition he had been using Cannabis for 
about 5 months. Although he had not experienced any adverse effects from Cannabis possible 






Fatalities, although rare, have occurred in association with its use. Five deaths, commonly as 
a result of cardiac arrhythmias, have been reported from the U.S.A.,9 while at least seven deaths in 
Britain have followed recreational use of M.D.M.A.10. The Republic of Ireland’s first fatality occurred 
in October 1991 when a seventeen year old youth died of acute cardiac failure as a direct consequence 
of the use of Ecstasy (Dr. D. O’Donovan, Coroner, personal communication). 
M.D.M.A. is commonly perceived as a safe recreational drug by many abusers. Based on the 
case presented and on other evidence from the literature we conclude it is a potentially hazardous drug 
and may (in some individuals) precipitate a prolonged psychosis. Further research will be needed to 
elucidate its exact mechanism of action and whether or not it causes neurodegenerative effects in 
humans. 
Acknowledgements 
We would like to thank Miss Eithne Cunningham for her help in typing this manuscript. 
References 
1. Gilman, A. G., Goodman, L.S. et al. Goodman a Gilman’s The Pharmacological Basis of 
Therapeutics (7th edition). 1985. New York: McMillan. 
2. Ricaurte, G. A. Studies of M.D.M.A.–induced neurotoxicity in nonhuman primates: A basis 
for evaluating long-term effects in humans. National Institute of Drug Abuse Research 
Monograph, 1989: Vol. 94, 306-22. 
3. Pan, H. S., Wang, R. Y. M.D.M.A.: further evidence that its action in the medial prefrontal 
cortex is mediated by the serotonergic system. Brain Res.1991: Vol. 539, 332-6. 
4. Peroutka, S. J., Newman, H., Harris, H. Subjective effects of 3, 4 - Methylenedioxymetham-
phetamine in recreational users. Neuropsychopharmacology 1988: 1, 273-7. 
5. Peroutka, S. J. Incidence of recreational use of 3, 4 - Methylenedioxymethamphetamine on an 
undergraduate campus. New England Journal Medicine 1987: Vol. 317 (24), 1542-3. 
6. Climko, R. P., Roehrich, H., Sweeney, D. R. et al. “Ecstasy” - a review of M.D.A. and 
M.D.M.A. International Journal of Psychiatric Medicine 1986/87: 26, 359-372. 
7. McGuire, P., Fahy, T. Chronic paranoid psychosis after misuse of M.D.M.A. (“Ecstasy”). 
British Medical Journal 1991: 302, 697. 
8. Creighton, F. J., Black, D. L., Hyde, C. E. ‘Ecstasy’ psychosis and flashbacks. British Journal 
of psychiatry 1991: 159, 713-15. 
9. Dowling, G. P., McDonough, E. T. “Eve” and “Ecstasy”. A report of five deaths associated 
with the use of M.D.E.A. and M.D.M.A. Journal of the American Medical Association 1987: 
257 (12), 1615-17. 
10. Henry, J. A. Ecstasy and the dance of death. British Medical Journal 1992: 305, 5-6. 
 
